BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26513294)

  • 1. An inducible transgenic mouse breast cancer model for the analysis of tumor antigen specific CD8+ T-cell responses.
    Bruns M; Wanger J; Utermöhlen O; Deppert W
    Oncotarget; 2015 Nov; 6(36):38487-503. PubMed ID: 26513294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell epitope strength in WAP-T mouse mammary carcinomas is an important determinant in PD1/PD-L1 immune checkpoint blockade therapy.
    Bruns M; Wanger J; Schumacher U; Deppert W
    Oncotarget; 2016 Oct; 7(40):64543-64559. PubMed ID: 27579535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy of WAP-T
    Bruns M; Deppert W
    Oncotarget; 2017 Sep; 8(40):67790-67804. PubMed ID: 28978072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early immunization induces persistent tumor-infiltrating CD8+ T cells against an immunodominant epitope and promotes lifelong control of pancreatic tumor progression in SV40 tumor antigen transgenic mice.
    Otahal P; Schell TD; Hutchinson SC; Knowles BB; Tevethia SS
    J Immunol; 2006 Sep; 177(5):3089-99. PubMed ID: 16920946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired CK1 delta activity attenuates SV40-induced cellular transformation in vitro and mouse mammary carcinogenesis in vivo.
    Hirner H; Günes C; Bischof J; Wolff S; Grothey A; Kühl M; Oswald F; Wegwitz F; Bösl MR; Trauzold A; Henne-Bruns D; Peifer C; Leithäuser F; Deppert W; Knippschild U
    PLoS One; 2012; 7(1):e29709. PubMed ID: 22235331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo expansion of the residual tumor antigen-specific CD8+ T lymphocytes that survive negative selection in simian virus 40 T-antigen-transgenic mice.
    Schell TD
    J Virol; 2004 Feb; 78(4):1751-62. PubMed ID: 14747540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.
    Slifka MK; Pagarigan R; Mena I; Feuer R; Whitton JL
    J Virol; 2001 Mar; 75(5):2377-87. PubMed ID: 11160741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of CD80/CD86 in generation and maintenance of functional virus-specific CD8+ T cells in mice infected with lymphocytic choriomeningitis virus.
    Grujic M; Bartholdy C; Remy M; Pinschewer DD; Christensen JP; Thomsen AR
    J Immunol; 2010 Aug; 185(3):1730-43. PubMed ID: 20601595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysis of infected cells in vivo by antiviral cytolytic T cells demonstrated by release of cell internal viral proteins.
    Kyburz D; Speiser DE; Battegay M; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1993 Jul; 23(7):1540-5. PubMed ID: 8325330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CD8+ T-cell response to lymphocytic choriomeningitis virus involves the L antigen: uncovering new tricks for an old virus.
    Kotturi MF; Peters B; Buendia-Laysa F; Sidney J; Oseroff C; Botten J; Grey H; Buchmeier MJ; Sette A
    J Virol; 2007 May; 81(10):4928-40. PubMed ID: 17329346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SV40 T-antigen induces breast cancer formation with a high efficiency in lactating and virgin WAP-SV-T transgenic animals but with a low efficiency in ovariectomized animals.
    Santarelli R; Tzeng YJ; Zimmermann C; Guhl E; Graessmann A
    Oncogene; 1996 Feb; 12(3):495-505. PubMed ID: 8637705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Private specificities of CD8 T cell responses control patterns of heterologous immunity.
    Kim SK; Cornberg M; Wang XZ; Chen HD; Selin LK; Welsh RM
    J Exp Med; 2005 Feb; 201(4):523-33. PubMed ID: 15710651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of CD8+ T cells in advanced-stage tumors and delay of disease progression following secondary immunization against an immunorecessive epitope.
    Ryan CM; Schell TD
    J Immunol; 2006 Jul; 177(1):255-67. PubMed ID: 16785521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Viral Antigen by the Liver Leads to Chronic Infection Through the Generation of Regulatory T Cells.
    Lapierre P; Janelle V; Langlois MP; Tarrab E; Charpentier T; Lamarre A
    Cell Mol Gastroenterol Hepatol; 2015 May; 1(3):325-341.e1. PubMed ID: 28210682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors.
    Tzeng YJ; Zimmermann C; Guhl E; Berg B; Avantaggiati ML; Graessmann A
    Oncogene; 1998 Apr; 16(16):2103-14. PubMed ID: 9572491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo ligation of CD40 enhances priming against the endogenous tumor antigen and promotes CD8+ T cell effector function in SV40 T antigen transgenic mice.
    Staveley-O'Carroll K; Schell TD; Jimenez M; Mylin LM; Tevethia MJ; Schoenberger SP; Tevethia SS
    J Immunol; 2003 Jul; 171(2):697-707. PubMed ID: 12847236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a ras oncogene peptide that contains both CD4(+) and CD8(+) T cell epitopes in a nested configuration and elicits both T cell subset responses by peptide or DNA immunization.
    Bristol JA; Orsini C; Lindinger P; Thalhamer J; Abrams SI
    Cell Immunol; 2000 Nov; 205(2):73-83. PubMed ID: 11104579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential loss of cytotoxic T lymphocyte responses to simian virus 40 large T antigen epitopes in T antigen transgenic mice developing osteosarcomas.
    Schell TD; Knowles BB; Tevethia SS
    Cancer Res; 2000 Jun; 60(11):3002-12. PubMed ID: 10850449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable epitope library carrying heavily mutated survivin-derived CTL epitope variants as a new class of efficient vaccine immunogen tested in a mouse model of breast cancer.
    NoeDominguez-Romero A; Zamora-Alvarado R; Servín-Blanco R; Pérez-Hernández EG; Castrillon-Rivera LE; Munguia ME; Acero G; Govezensky T; Gevorkian G; Manoutcharian K
    Hum Vaccin Immunother; 2014; 10(11):3201-13. PubMed ID: 25483665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virus.
    Saron MF; Fayolle C; Sebo P; Ladant D; Ullmann A; Leclerc C
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3314-9. PubMed ID: 9096390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.